Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-19,200
Closed -$299K 56
2015
Q1
$299K Hold
19,200
0.07% 114
2014
Q4
$264K Buy
+19,200
New +$235K 0.06% 115

Other funds holding DXCM

300 North Capital's DXCM Position: Q2 2015 in Review

300 North Capital sold out of DexCom (DXCM) in Q2 2015, closing a stake of 19,200 shares — an estimated $299K sold.

300 North Capital first reported a position in DXCM in Q4 2014 and held it in 2 quarters. The position peaked at $299K in Q1 2015. 258 funds tracked by Wall St. Rank hold DXCM as of Q2 2015.

  • 300 North Capital reported no remaining DexCom position as of Q2 2015 after selling out during the quarter.
  • 300 North Capital sold 19,200 DexCom shares in Q2 2015, an estimated $299K.
  • 300 North Capital first reported a position in DexCom in Q4 2014 and held it in 2 quarters.
  • 300 North Capital's DexCom position peaked at $299K in Q1 2015.
  • 258 funds tracked by Wall St. Rank held DexCom as of Q2 2015.

Based on 300 North Capital's 13F filing for Q2 2015, filed 30 Jul 2015.